
Andrew D. Kosar
Supervisory Patent Examiner (ID: 5699, Phone: (571)272-0913 , Office: P/1625 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1625, 1600, 1654, 1622 |
| Total Applications | 945 |
| Issued Applications | 290 |
| Pending Applications | 356 |
| Abandoned Applications | 302 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6517164
[patent_doc_number] => 20100261700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'BETA-LACTAMASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/757769
[patent_app_country] => US
[patent_app_date] => 2010-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 20295
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261700.pdf
[firstpage_image] =>[orig_patent_app_number] => 12757769
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/757769 | BETA-LACTAMASE INHIBITORS | Apr 8, 2010 | Abandoned |
Array
(
[id] => 6350866
[patent_doc_number] => 20100249159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'RHO-KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/726660
[patent_app_country] => US
[patent_app_date] => 2010-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5036
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20100249159.pdf
[firstpage_image] =>[orig_patent_app_number] => 12726660
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/726660 | RHO-KINASE INHIBITORS | Mar 17, 2010 | Abandoned |
Array
(
[id] => 13668
[patent_doc_number] => 07807635
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-10-05
[patent_title] => 'Pan-antiviral peptides for protein kinase inhibition'
[patent_app_type] => utility
[patent_app_number] => 12/691902
[patent_app_country] => US
[patent_app_date] => 2010-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4969
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807635.pdf
[firstpage_image] =>[orig_patent_app_number] => 12691902
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/691902 | Pan-antiviral peptides for protein kinase inhibition | Jan 21, 2010 | Issued |
Array
(
[id] => 4550405
[patent_doc_number] => RE042013
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2010-12-28
[patent_title] => 'Macrocyclic modulators of the ghrelin receptor'
[patent_app_type] => reissue
[patent_app_number] => 12/636048
[patent_app_country] => US
[patent_app_date] => 2009-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 34
[patent_no_of_words] => 63594
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/042/RE042013.pdf
[firstpage_image] =>[orig_patent_app_number] => 12636048
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/636048 | Macrocyclic modulators of the ghrelin receptor | Dec 10, 2009 | Issued |
Array
(
[id] => 4617202
[patent_doc_number] => RE042624
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2011-08-16
[patent_title] => 'Methods of using macrocyclic modulators of the ghrelin receptor'
[patent_app_type] => reissue
[patent_app_number] => 12/635871
[patent_app_country] => US
[patent_app_date] => 2009-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 34
[patent_no_of_words] => 63789
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/042/RE042624.pdf
[firstpage_image] =>[orig_patent_app_number] => 12635871
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/635871 | Methods of using macrocyclic modulators of the ghrelin receptor | Dec 10, 2009 | Issued |
Array
(
[id] => 6245465
[patent_doc_number] => 20100135966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'AGENTS FOR TREATING FLAVIVIRIDAE INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/624271
[patent_app_country] => US
[patent_app_date] => 2009-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18182
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20100135966.pdf
[firstpage_image] =>[orig_patent_app_number] => 12624271
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/624271 | AGENTS FOR TREATING FLAVIVIRIDAE INFECTIONS | Nov 22, 2009 | Abandoned |
Array
(
[id] => 7568043
[patent_doc_number] => 20110288106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'ADENINE RECEPTOR LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 13/000780
[patent_app_country] => US
[patent_app_date] => 2009-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12839
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20110288106.pdf
[firstpage_image] =>[orig_patent_app_number] => 13000780
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000780 | ADENINE RECEPTOR LIGANDS | Jun 28, 2009 | Abandoned |
Array
(
[id] => 6163525
[patent_doc_number] => 20110160300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'Renin Inhibitors and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/999969
[patent_app_country] => US
[patent_app_date] => 2009-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23385
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160300.pdf
[firstpage_image] =>[orig_patent_app_number] => 12999969
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999969 | Renin Inhibitors and Methods of Use Thereof | Jun 17, 2009 | Abandoned |
Array
(
[id] => 6144611
[patent_doc_number] => 20110130378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'EZETIMIBE PROCESS AND COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/994357
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3072
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20110130378.pdf
[firstpage_image] =>[orig_patent_app_number] => 12994357
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/994357 | EZETIMIBE PROCESS AND COMPOSITION | May 25, 2009 | Abandoned |
Array
(
[id] => 5480674
[patent_doc_number] => 20090203631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'PEPTIDE DEFORMYLASE INHIBITORS AS NOVEL ANTIBIOTICS'
[patent_app_type] => utility
[patent_app_number] => 12/424282
[patent_app_country] => US
[patent_app_date] => 2009-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9986
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203631.pdf
[firstpage_image] =>[orig_patent_app_number] => 12424282
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/424282 | PEPTIDE DEFORMYLASE INHIBITORS AS NOVEL ANTIBIOTICS | Apr 14, 2009 | Abandoned |
Array
(
[id] => 4539782
[patent_doc_number] => 07875590
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-25
[patent_title] => 'Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins'
[patent_app_type] => utility
[patent_app_number] => 12/414715
[patent_app_country] => US
[patent_app_date] => 2009-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8745
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/875/07875590.pdf
[firstpage_image] =>[orig_patent_app_number] => 12414715
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/414715 | Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins | Mar 30, 2009 | Issued |
Array
(
[id] => 5342389
[patent_doc_number] => 20090181039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'CONJUGATES WITH REDUCED ADVERSE SYSTEMIC EFFECTS'
[patent_app_type] => utility
[patent_app_number] => 12/407850
[patent_app_country] => US
[patent_app_date] => 2009-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8311
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181039.pdf
[firstpage_image] =>[orig_patent_app_number] => 12407850
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/407850 | CONJUGATES WITH REDUCED ADVERSE SYSTEMIC EFFECTS | Mar 19, 2009 | Abandoned |
Array
(
[id] => 216815
[patent_doc_number] => 07611724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-03
[patent_title] => 'Method of producing FR901228'
[patent_app_type] => utility
[patent_app_number] => 12/396773
[patent_app_country] => US
[patent_app_date] => 2009-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 3188
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/611/07611724.pdf
[firstpage_image] =>[orig_patent_app_number] => 12396773
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/396773 | Method of producing FR901228 | Mar 2, 2009 | Issued |
Array
(
[id] => 5404572
[patent_doc_number] => 20090239886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'Substituted xanthine derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/380579
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 32354
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239886.pdf
[firstpage_image] =>[orig_patent_app_number] => 12380579
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/380579 | Substituted xanthine derivatives | Feb 26, 2009 | Abandoned |
Array
(
[id] => 5436188
[patent_doc_number] => 20090170775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'VASOACTIVE INTESTINAL POLYPEPTIDE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/370842
[patent_app_country] => US
[patent_app_date] => 2009-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 25235
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170775.pdf
[firstpage_image] =>[orig_patent_app_number] => 12370842
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/370842 | VASOACTIVE INTESTINAL POLYPEPTIDE COMPOSITIONS | Feb 12, 2009 | Abandoned |
Array
(
[id] => 6189901
[patent_doc_number] => 20110172200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'USE OF INHIBITOR OF BETA-LACTAMASES AND ITS COMBINATION WITH BETA-LACTAM ANTIBIOTICS'
[patent_app_type] => utility
[patent_app_number] => 12/864671
[patent_app_country] => US
[patent_app_date] => 2009-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12710
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20110172200.pdf
[firstpage_image] =>[orig_patent_app_number] => 12864671
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/864671 | USE OF INHIBITOR OF BETA-LACTAMASES AND ITS COMBINATION WITH BETA-LACTAM ANTIBIOTICS | Jan 27, 2009 | Abandoned |
Array
(
[id] => 6603334
[patent_doc_number] => 20100292463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'PROCESS FOR PRODUCTION OF B-LACTAM COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 12/864296
[patent_app_country] => US
[patent_app_date] => 2009-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5761
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292463.pdf
[firstpage_image] =>[orig_patent_app_number] => 12864296
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/864296 | PROCESS FOR PRODUCTION OF B-LACTAM COMPOUND | Jan 21, 2009 | Abandoned |
Array
(
[id] => 6503576
[patent_doc_number] => 20100286389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'STABLE CRYSTAL OF BETA-LACTAM COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 12/735042
[patent_app_country] => US
[patent_app_date] => 2008-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8159
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286389.pdf
[firstpage_image] =>[orig_patent_app_number] => 12735042
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/735042 | STABLE CRYSTAL OF BETA-LACTAM COMPOUND | Dec 10, 2008 | Abandoned |
Array
(
[id] => 6136394
[patent_doc_number] => 20110009368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'SOLID FORMS OF TENOFOVIR DISOPROXIL'
[patent_app_type] => utility
[patent_app_number] => 12/747234
[patent_app_country] => US
[patent_app_date] => 2008-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 17665
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20110009368.pdf
[firstpage_image] =>[orig_patent_app_number] => 12747234
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/747234 | SOLID FORMS OF TENOFOVIR DISOPROXIL | Dec 10, 2008 | Abandoned |
Array
(
[id] => 6295916
[patent_doc_number] => 20100240537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'Substituted 6-(alkylbenzylamino)purine derivatives for use as cytokinin receptor antagonists and preparations containing these derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/680762
[patent_app_country] => US
[patent_app_date] => 2008-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9352
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240537.pdf
[firstpage_image] =>[orig_patent_app_number] => 12680762
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/680762 | Substituted 6-(alkylbenzylamino)purine derivatives for use as cytokinin receptor antagonists and preparations containing these derivatives | Oct 2, 2008 | Abandoned |